secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENXBIO Inc. (RGNX)
CIK:        0001590877
Form:       8-K
Filed at:   2026-08-25T20:57:06+00:00
Accession:  0001193125-26-365287
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

REGENXBIO appoints Greg Ciongoli to board; two directors retire effective Aug 25, 2026
--------------------------------------------------------------------------------

- Ciongoli elected as independent Class II director, term expires at 2029 annual meeting.
- Granted initial equity award with $550,000 fair value (75% option, 25% RSUs), exercise price $8.91, 3-year vesting.
- Annual board retainer of $45,000 plus $10,000 audit and $5,000 nominating committee retainers.
- Jean Bennett and Jerry Karabelas resigned as directors; will serve as advisors until February 2027.
- Board size reduced to nine directors effective immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590877/000119312526365287/0001193125-26-365287-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590877/000119312526365287/rgnx-20260825.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-365287

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer